Tongrentang Healthcare (2667.HK) fell more than 6% in Hong Kong trading to HK$2.815. The company's IPO stabilisation period ended on August 1, during which the stabilisation manager purchased approximately 5.41 million H shares at prices ranging from HK$2.69 to HK$4.76. The over-allotment option was not exercised and has lapsed.
According to Hong Kong Exchange data, CICC increased its stake in Tongrentang Healthcare on July 30, acquiring 250,000 shares at an average price of approximately HK$2.7143 per share, bringing its total holding to 12.19%.